Reducing tinnitus with neurofeedback
Epilepsy monitoring and seizure forecasts
Thought controlled arm to help people with paralysis re...
Blurring the boundaries between living tissue and elect...
Brain stimulation to help people with dyslexia
Personalized robots to improve stroke rehabilitation
Discover the Wyss Center
High risk, high reward projects
The Wyss Center provides experts, development platforms and funding to support high risk, high reward technology-linked solutions to treat or diagnose nervous system disorders. We create prototype devices suitable for humans and then support initial human clinical trials to accelerate the path to commercialization.
Current program areas
- Movement restoration – Bionic nervous system to restore hand function, communication and walking
- Stroke rehabilitation – Precision stroke rehabilitation with novel integrated neurotechnology and robotics
- Brain circuits – A minimally invasive diagnostic and therapy platform for epilepsy, dyslexia and tinnitus
- Sensory – Virtual reality solutions for sight restoration and diagnostics
- Advanced technology projects:
- Flexible electrodes
- Brain on a chip – High throughput in vitro human ‘mini-brains’ for testing new microelectrode materials and geometries
- Geneva array – novel multielectrode interface
We welcome informal inquiries, from anywhere in the world, about projects that could complement our existing programs.
Repairing the nervous system with technology
Neurotechnology describes devices that can interact with the nervous system. Translating neurotechnology from the laboratory into clinical and commercial products has the potential to revolutionize the treatment of neurological diseases and disorders including paralysis as a result of stroke or trauma, pain, epilepsy, neuromuscular disease, motor neurone disease, Alzheimer’s disease and Parkinson’s disease.
Creating effective neurotechnologies depends upon knowledge and skill from neuroscience, engineering and clinical medicine to recognise credible innovations, build and test prototypes then advance them to early stage human clinical trials.
This process requires clinical input, regulatory and business expertise from the very early stages to ensure sound design, feasible implementation for human use and commercial viability.
The Wyss Center combines these interdisciplinary skills with platforms equipped with state of the art infrastructure to enable the research and development needed to create and test cutting edge neurotechnology.
“We are here to facilitate the design, development and implementation of new technology that can radically improve the lives of people living with nervous system disorders.”
Professor John Donoghue
Director of the Wyss Center